Concepedia

Michael McClurg

MM

5

Publications

677

Citations

5

H-Index

1990

Active since

Affiliations

Ligand Pharmaceuticals (United States)(Current)

Michael McClurg is an author at Ligand Pharmaceuticals (United States) specializing in medicine, immunology, and immune cell activation.

Top concepts

Publications per year

1990–1995

5

Publications

5

Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells

Marcus F. Boehm, Michael McClurg, E. Berger et al. · Journal of Medicinal Chemistry · 1995 · 338 citations · Full text

Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism.

Elizabeth A. Allegretto, Michael McClurg, Steven B. Lazarchik et al. · Journal of Biological Chemistry · 1993 · 182 citations · Full text

, , +19

Synthesis of high specific activity tritium-labeled [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties

Marcus F. Boehm, Michael McClurg, Charles Pathirana et al. · Journal of Medicinal Chemistry · 1994 · 83 citations · Full text

ChemInform Abstract: Design and Synthesis of Potent Retinoid X Receptor Selective Ligands that Induce Apoptosis in Leukemia Cells.

Marcus F. Boehm, L. Zhang, Lingtong Zhi et al. · ChemInform · 1995 · 49 citations

, , +10

Suppression of human B lymphocyte activation by ß-endorphin

Edward L. Morgan, Michael McClurg, Jodee A. Janda · Journal of Neuroimmunology · 1990 · 25 citations

, , +2

Rows per page

1–5 of 5